An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers

International Journal of Cancer

Volumn 79, Issue 4, 1998, Pages 334-342

  Taylor, Jacqueline ^a   Tymboura, Margarita ^a   Pace, Paul E ^a   A'Hern, Roger P ^b   Desai, Anil J ^a   Shousha, Sami ^a   Coombes, R Charles ^a   Ali, Simak ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER GRADING; CANCER SUSCEPTIBILITY; DISEASE COURSE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; ANIMALS; BRCA1 PROTEIN; BREAST; BREAST NEOPLASMS; COS CELLS; DISEASE PROGRESSION; HELA CELLS; HUMANS; IMMUNE SERA; IMMUNOHISTOCHEMISTRY; TRANSFECTION;

EID: 0031874053     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980821)79:4<334::AID-IJC5>3.0.CO;2-W     Document Type: Article

References (26)

1. CHEN, Y., CHEN, C.-F., RILEY, D.J., ALLRED, D.C., CHEN, P.-L., VON HOFF, D., OSBORNE, C.K. and LEE, W.-H., Aberrant subcellular localization of BRCA1 in breast cancer. Science, 270, 789-791 (1995).
2. CHEN, Y., CHEN, P.-L., RILEY, D., LEE, W.-H., ALLRED, D.C. and OSBORNE, C.K., Location of BRCA1 in human breast and ovarian cancer cells. Science, 272, 125-126 (1996).
3. CROPP, C.S., NEVANLINNA, H.A., PYRHONEN, S., STENMAN, U.-F., SALMIKANGAS, P., ALBERTSEN, H., WHITE, R. and CALLAHAN, R., Evidence for involvement of BRCA1 in sporadic breast carcinomas. Cancer Res., 54, 2548-2551 (1994).
4. EASTON, D.R.F., FORD, D., BISHOP, D.T. and THE BREAST CANCER LINKAGE CONSORTIUM, Breast and ovarian cancer incidence in BRCA1-mutation carriers. Amer. J. hum. Genet., 56, 265-271 (1995).
5. FITZGERALD, M.G. and 18 OTHERS, Germ-line BRCA1 mutations in Jewish and non-Jewish women with early onset breast cancer. New Engl. J. Med., 334, 143-149 (1996).
6. FUTREAL, P.A. and 26 OTHERS, BRCA1 mutations in primary breast and ovarian carcinomas. Science, 266, 120-122 (1994).
7. GAYTHER, S.A. and 15 OTHERS, Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a gentotypephenotype correlation. Nature (Genet.), 11, 428-433 (1995).
8. HOLT, J.T., THOMPSON, M.E., SZABO, C., ROBINSON-BENION, C., ARTEAGA, C.L., KING, M.C. and JENSEN, R.A., Growth retardation and tumour inhibition by BRCA1. Nature (Genet.), 12, 298-302 (1996).
9. JACOBS, I.J., SMITH, S.A., WISEMAN, R.W., FUTREAL, P.A., HARRINGTON, T., OSBORNE, R.J., LEECH, V., MOLYNEUX, A., BERCHUCK, A., PONDER, B.A.J. and BAST, R.C. Jr., A deletion unit on chromosome 17q in epithelial ovarian tumours distal to the familial breast/ovarian cancer locus. Cancer Res., 53, 1218-1221 (1993).
10. JENSEN, R.A., THOMPSON, M.E., JETTON, T.L., SZABO, C.I., VAN DER MEER, R., HELOU, B., TRONICK, S.R., PAGE, D.L., KING, M.-C. and HOLT, J.T., BRCA1 is secreted and exhibits properties of a granin. Nature Genet., 12, 303-308 (1996).
11. LANGSTON, A.A., MALONE, K.E., THOMPSON, J.D., DALIN, J.R. and OSTRANDER, E.A., BRCA1 mutations in a population-based sample of young women with breast cancer. New Engl. J. Med., 334, 137-142 (1996).
12. MERAJVER, S.D., PHAM, T.M., CADUFF, R.F., CHEN, M., POY, E.L., COONEY, K.A., WEBER, B.L., COLLINS, F.S., JOHNSTON, C. and FRANK, T.S., Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature (Genet.), 9, 439-143 (1995).
13. MIKI, Y. and 44 OTHERS. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71 (1994).
14. MORGAN, J.M., NAVABI, H., SCHMID, K.W. and JASANI, B., Possible role of tissue bound calcium ions in citrate-mediated high temperature antigen retrieval. J. Pathol., 174, 301-307 (1994).
15. NAGAI, M.A. and 14 OTHERS, Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours. Genes Chromosomes Cancer, 11, 58-62 (1994).
16. SAITO, H., INAZAWA, J., SAITO, S., KASUMI, F., KOI, S., SAGAE, S., KUDO, R. SAITO, J., NODA, K. and NAKAMURA, Y., Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2 cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res., 53, 3382-3385 (1993).
17. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press, New York (1989).
18. SCULLY, R., CHEN, J., OCHS, R.L., KEEGAN, K., HOELESTRA, M., FEUNTEUN, J. and LIVINGSTON, D.M., Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell, 90, 425-436 (1997a).
19. SCULLY, R., CHEN, J., PLUG, A., XIAO, Y., WEAVER, D., FEUNTEUN, J., ASHLEY, T. and LIVINGSTON, D.M., Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell, 88, 265-275 (1997b).
20. SCULLY, R., GANESAN, S., BROWN, M., DE CAPRIO, J.A., CANNESTUA, S.A., FEUNTEUN, J., SCHNITT, S. and LIVINGSTON, D.M., Location of BRCA1 in human breast and ovarian cell lines. Science, 272, 123-125 (1996).
21. SHATTUCK-EIDENS, D. and 58 OTHERS, A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. J. amer. med. Ass., 272, 535-541 (1995).
22. SMITH, S.A., EASTON, D.F., EVANS, D.G.R. and PONDER, B.A.J., Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature (Genet.), 2, 128-131 (1992).
23. SOBOL, H., STOPPA-LYONNET, D., BRESSAC-DE PAILLERETS, B., PEYRAT, J.-P., KERANGUEVEN, F., JANIN, N., NOGUCHI, T., EISINGER, F., GUINEBRETIERE, J.-M., JACQUEMIER, J. and BIRNBAUM, D., Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancer. Cancer Res., 56, 3216-3219 (1996).
24. THAKAR, S., ZHANG, H.B., PENG, Y., LE, H., CARROLL, B., WARD, T., YAO, J., FARID, L.M., COUCH, F.J., WILSON, R.B. and WEBER, B.L., Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. cell. Biol., 17, 444-454 (1997).
25. THOMPSON, M.E., JENSEN, R.A., OBERMILLER, P.S., PAGE, D.L. and HOLT, J.T., Decrease expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature (Genet.), 9, 444-450 (1995).
26. WILSON, C.A., PAYTON, M.N., ELLIOTT, G.S., BUAAS, F.W., CAJULIS, E.E., GROSSHANS, D., RAMOS, L., REESE, D.M., SLAMON, D.J. and CALZONE, F.J., Differential subcellular localisation, expression and biological toxicity of BRCA1 and the splice variant BRCA1-D11b. Oncogene, 14, 1-16 (1997).